Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development

Drug Development & Delivery Publishes Overview of Obesity Formulation Development Results Demonstrating Significant Transdermal Penetration Using Invisicare Technology LAS VEGAS, NV / ACCESSWIRE / October 3, 2024 / Skinvisible Pharmaceuticals, Inc. …
Jetzt den vollständigen Artikel lesen